These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 3074841)
1. Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex. Albuquerque EX; Aracava Y; Cintra WM; Brossi A; Schönenberger B; Deshpande SS Braz J Med Biol Res; 1988; 21(6):1173-96. PubMed ID: 3074841 [TBL] [Abstract][Full Text] [Related]
2. Multiple actions of anticholinesterase agents on chemosensitive synapses: molecular basis for prophylaxis and treatment of organophosphate poisoning. Albuquerque EX; Deshpande SS; Kawabuchi M; Aracava Y; Idriss M; Rickett DL; Boyne AF Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S182-203. PubMed ID: 2868960 [TBL] [Abstract][Full Text] [Related]
3. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. Shaw KP; Aracava Y; Akaike A; Daly JW; Rickett DL; Albuquerque EX Mol Pharmacol; 1985 Dec; 28(6):527-38. PubMed ID: 2417099 [TBL] [Abstract][Full Text] [Related]
4. Noncompetitive blockade of the nicotinic acetylcholine receptor-ion channel complex by an irreversible cholinesterase inhibitor. Rao KS; Aracava Y; Rickett DL; Albuquerque EX J Pharmacol Exp Ther; 1987 Jan; 240(1):337-44. PubMed ID: 2433427 [TBL] [Abstract][Full Text] [Related]
5. The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against Soman poisoning in vivo. Xia DY; Wang LX; Pei SQ Fundam Appl Toxicol; 1981; 1(2):217-21. PubMed ID: 7184786 [TBL] [Abstract][Full Text] [Related]
6. Interactions of edrophonium, physostigmine and methanesulfonyl fluoride with the snake end-plate acetylcholine receptor-channel complex. Fiekers JF J Pharmacol Exp Ther; 1985 Sep; 234(3):539-49. PubMed ID: 2411911 [TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats. Yamamoto K; Sawada Y; Iga T J Pharmacokinet Biopharm; 1996 Aug; 24(4):327-48. PubMed ID: 9044164 [TBL] [Abstract][Full Text] [Related]
8. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies. Ikeda SR; Aronstam RS; Daly JW; Aracava Y; Albuquerque EX Mol Pharmacol; 1984 Sep; 26(2):293-303. PubMed ID: 6090884 [TBL] [Abstract][Full Text] [Related]
9. The interaction of anticholinesterase agents with the acetylcholine receptor-ionic channel complex. Albuquerque EX; Akaike A; Shaw KP; Rickett DL Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S27-33. PubMed ID: 6327444 [TBL] [Abstract][Full Text] [Related]
10. Biochemical interactions of carbamates and ecothiophate with the activated conformation of nicotinic acetylcholine receptor. Mansour NA; Valdes JJ; Shamoo AE; Annau Z J Biochem Toxicol; 1987; 2():25-42. PubMed ID: 3508476 [TBL] [Abstract][Full Text] [Related]
11. Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells. Storch A; Schrattenholz A; Cooper JC; Abdel Ghani EM; Gutbrod O; Weber KH; Reinhardt S; Lobron C; Hermsen B; Soskiç V Eur J Pharmacol; 1995 Aug; 290(3):207-19. PubMed ID: 7589215 [TBL] [Abstract][Full Text] [Related]
12. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist. Varanda WA; Aracava Y; Sherby SM; VanMeter WG; Eldefrawi ME; Albuquerque EX Mol Pharmacol; 1985 Aug; 28(2):128-37. PubMed ID: 2410768 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiological estimation of the actions of acetylcholinesterase inhibitors on acetylcholine receptor and cholinesterase in physically isolated Aplysia neurones. Oyama Y; Hori N; Evans ML; Allen CN; Carpenter DO Br J Pharmacol; 1989 Mar; 96(3):573-82. PubMed ID: 2720293 [TBL] [Abstract][Full Text] [Related]
14. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties. Pascuzzo GJ; Akaike A; Maleque MA; Shaw KP; Aronstam RS; Rickett DL; Albuquerque EX Mol Pharmacol; 1984 Jan; 25(1):92-101. PubMed ID: 6323955 [TBL] [Abstract][Full Text] [Related]
15. Contractile and phosphatidylinositol responses of rat trachea to anticholinesterase drugs. Shibata O; Tsuda A; Makita T; Iwanaga S; Hara T; Shibata S; Sumikawa K Can J Anaesth; 1998 Dec; 45(12):1190-5. PubMed ID: 10051938 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning. Deshpande SS; Viana GB; Kauffman FC; Rickett DL; Albuquerque EX Fundam Appl Toxicol; 1986 Apr; 6(3):566-77. PubMed ID: 3699340 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor. Sherby SM; Eldefrawi AT; Albuquerque EX; Eldefrawi ME Mol Pharmacol; 1985 Mar; 27(3):343-8. PubMed ID: 3974572 [TBL] [Abstract][Full Text] [Related]
18. Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs. Zwart R; van Kleef RG; Gotti C; Smulders CJ; Vijverberg HP J Neurochem; 2000 Dec; 75(6):2492-500. PubMed ID: 11080202 [TBL] [Abstract][Full Text] [Related]
19. Clinical concentrations of edrophonium enhance desensitization of the nicotinic acetylcholine receptor. Yost CS; Maestrone E Anesth Analg; 1994 Mar; 78(3):520-6. PubMed ID: 8109771 [TBL] [Abstract][Full Text] [Related]
20. The use of carbamates, atropine, and 2-pyridine aldoxime methoiodide in the protection of Artemia salina against poisoning by carbophenothion. Sánchez-Fortún S; Barahona V Environ Toxicol Chem; 2001 Sep; 20(9):2008-13. PubMed ID: 11521828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]